@article{farge:hal-03576022,
TITLE = {Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study},
AUTHOR = {Farge, Dominique and Loisel, S{\'e}verine and Resche-Rigon, Matthieu and Lansiaux, Pauline and Colmegna, Ines and Langlais, David and Charles, Catney and Pugnet, Gregory and Maria, Alexandre Thibault Jacques and Chatelus, Emmanuel and Martin, Thierry and Hachulla, Eric and Kheav, Vissal David and Lambert, Nathalie C. and Wang, Han Chen and Michonneau, David and Martinaud, Christophe and Sensebe, Luc and Crast, Audrey and Tarte, Karin},
URL = {https://hal.science/hal-03576022},
JOURNAL = {The Lancet Rheumatology},
PUBLISHER = {Elsevier},
VOLUME = {4},
NUMBER = {2},
PAGES = {E91-E104},
YEAR = {2022},
MONTH = Feb, DOI = {10.1016/S2665-9913(21)00326-X},
PDF = {https://hal.science/hal-03576022/file/Farge%20et%20al%20-%202022%20-%20Safety%20and%20preliminary%20efficacy%20of%20allogeneic%20bone.pdf},
HAL_ID = {hal-03576022},
HAL_VERSION = {v1},
}